| 1. Executive Summary |
| 2. Global Glycomics/Glycobiology Market Introduction |
| 2.1. Global Glycomics/Glycobiology Market – Taxonomy |
| 2.2. Global Glycomics/Glycobiology Market –Definitions |
| 2.2.1. By Product |
| 2.2.2. By Application |
| 2.2.3. By End Use |
| 2.2.4. By Region |
| 3. Global Glycomics/Glycobiology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Glycomics/Glycobiology Market Dynamic Factors – Impact Analysis |
| 3.6. Global Glycomics/Glycobiology Market – Competition Landscape |
| 4. Global Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 |
| 4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Glycomics/Glycobiology Market, By Product, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.1. Enzymes |
| 5.1.1. Glycosidases |
| 5.1.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.1.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4. Market Opportunity Analysis |
| 5.1.5. Neuraminidases |
| 5.1.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.1.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.8. Market Opportunity Analysis |
| 5.1.9. Glycosyltransferases |
| 5.1.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.1.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.12. Market Opportunity Analysis |
| 5.1.13. Sialytransferases |
| 5.1.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.1.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.16. Market Opportunity Analysis |
| 5.1.17. Others |
| 5.1.18. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.1.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.20. Market Opportunity Analysis |
| 5.2. Kits |
| 5.2.1. Glycan Labelling Kits |
| 5.2.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.2.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.4. Market Opportunity Analysis |
| 5.2.5. Glycan Purification Kits |
| 5.2.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.2.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.8. Market Opportunity Analysis |
| 5.2.9. Glycan Releases Kits |
| 5.2.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.2.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.12. Market Opportunity Analysis |
| 5.2.13. Others |
| 5.2.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.2.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.16. Market Opportunity Analysis |
| 5.3. Reagents |
| 5.3.1. Glycoporteins |
| 5.3.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.3.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.4. Market Opportunity Analysis |
| 5.3.5. Monosaccharides |
| 5.3.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.3.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.8. Market Opportunity Analysis |
| 5.3.9. Oligosaccharides |
| 5.3.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.3.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.12. Market Opportunity Analysis |
| 5.3.13. Others |
| 5.3.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.3.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.16. Market Opportunity Analysis |
| 5.4. Instruments |
| 5.4.1. Mass Spectrometers |
| 5.4.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.4.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.4. Market Opportunity Analysis |
| 5.4.5. HPLC |
| 5.4.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.4.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.8. Market Opportunity Analysis |
| 5.4.9. MALDI-TOF |
| 5.4.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.4.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.12. Market Opportunity Analysis |
| 5.4.13. Array Systems |
| 5.4.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.4.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.16. Market Opportunity Analysis |
| 5.4.17. Others |
| 5.4.18. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 5.4.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.20. Market Opportunity Analysis |
| 6. Global Glycomics/Glycobiology Market, By Application, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 6.1. Drug Discovery and Development |
| 6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostics |
| 6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Glycomics/Glycobiology Market, By End User, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 7.1. Academic & Research Institutes |
| 7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceutical & Biotechnology Companies |
| 7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. CROs |
| 7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Glycomics/Glycobiology Market Forecast, By Region, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, By End User and Region, 2022- 2028 |
| 9. North America Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 9.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Enzymes |
| 9.1.1.1. Glycosidases |
| 9.1.1.2. Neuraminidases |
| 9.1.1.3. Glycosyltransferases |
| 9.1.1.4. Sialytransferases |
| 9.1.1.5. Others |
| 9.1.2. Kits |
| 9.1.2.1. Glycan Labelling Kits |
| 9.1.2.2. Glycan Purification Kits |
| 9.1.2.3. Glycan Releases Kits |
| 9.1.2.4. Others |
| 9.1.3. Reagents |
| 9.1.3.1. Glycoporteins |
| 9.1.3.2. Monosaccharides |
| 9.1.3.3. Oligosaccharides |
| 9.1.3.4. Others |
| 9.1.4. Instruments |
| 9.1.4.1. Mass Spectrometers |
| 9.1.4.2. HPLC |
| 9.1.4.3. MALDI-TOF |
| 9.1.4.4. Array Systems |
| 9.1.4.5. Others |
| 9.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Drug Discovery & Development |
| 9.2.2. Diagnostics |
| 9.2.3. Others |
| 9.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Academic & Research Institutes |
| 9.3.2. Pharmaceutical & Biotechnology Companies |
| 9.3.3. CROs |
| 9.3.4. Others |
| 9.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. U.S. |
| 9.4.2. Canada |
| 9.5. North America Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028 |
| 9.6. North America Glycomics/Glycobiology Market Dynamics – Trends |
| 10. Europe Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 10.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Enzymes |
| 10.1.1.1. Glycosidases |
| 10.1.1.2. Neuraminidases |
| 10.1.1.3. Glycosyltransferases |
| 10.1.1.4. Sialytransferases |
| 10.1.1.5. Others |
| 10.1.2. Kits |
| 10.1.2.1. Glycan Labelling Kits |
| 10.1.2.2. Glycan Purification Kits |
| 10.1.2.3. Glycan Releases Kits |
| 10.1.2.4. Others |
| 10.1.3. Reagents |
| 10.1.3.1. Glycoporteins |
| 10.1.3.2. Monosaccharides |
| 10.1.3.3. Oligosaccharides |
| 10.1.3.4. Others |
| 10.1.4. Instruments |
| 10.1.4.1. Mass Spectrometers |
| 10.1.4.2. HPLC |
| 10.1.4.3. MALDI-TOF |
| 10.1.4.4. Array Systems |
| 10.1.4.5. Others |
| 10.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Drug Discovery & Development |
| 10.2.2. Diagnostics |
| 10.2.3. Others |
| 10.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Academic & Research Institutes |
| 10.3.2. Pharmaceutical & Biotechnology Companies |
| 10.3.3. CROs |
| 10.3.4. Others |
| 10.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028 |
| 10.6. Europe Glycomics/Glycobiology Market Dynamics – Trends |
| 11. Asia-Pacific Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 11.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Enzymes |
| 11.1.1.1. Glycosidases |
| 11.1.1.2. Neuraminidases |
| 11.1.1.3. Glycosyltransferases |
| 11.1.1.4. Sialytransferases |
| 11.1.1.5. Others |
| 11.1.2. Kits |
| 11.1.2.1. Glycan Labelling Kits |
| 11.1.2.2. Glycan Purification Kits |
| 11.1.2.3. Glycan Releases Kits |
| 11.1.2.4. Others |
| 11.1.3. Reagents |
| 11.1.3.1. Glycoporteins |
| 11.1.3.2. Monosaccharides |
| 11.1.3.3. Oligosaccharides |
| 11.1.3.4. Others |
| 11.1.4. Instruments |
| 11.1.4.1. Mass Spectrometers |
| 11.1.4.2. HPLC |
| 11.1.4.3. MALDI-TOF |
| 11.1.4.4. Array Systems |
| 11.1.4.5. Others |
| 11.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Drug Discovery & Development |
| 11.2.2. Diagnostics |
| 11.2.3. Others |
| 11.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Academic & Research Institutes |
| 11.3.2. Pharmaceutical & Biotechnology Companies |
| 11.3.3. CROs |
| 11.3.4. Others |
| 11.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028 |
| 11.6. Asia-Pacific Glycomics/Glycobiology Market Dynamics – Trends |
| 12. Latin America Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
| 12.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Enzymes |
| 12.1.1.1. Glycosidases |
| 12.1.1.2. Neuraminidases |
| 12.1.1.3. Glycosyltransferases |
| 12.1.1.4. Sialytransferases |
| 12.1.1.5. Others |
| 12.1.2. Kits |
| 12.1.2.1. Glycan Labelling Kits |
| 12.1.2.2. Glycan Purification Kits |
| 12.1.2.3. Glycan Releases Kits |
| 12.1.2.4. Others |
| 12.1.3. Reagents |
| 12.1.3.1. Glycoporteins |
| 12.1.3.2. Monosaccharides |
| 12.1.3.3. Oligosaccharides |
| 12.1.3.4. Others |
| 12.1.4. Instruments |
| 12.1.4.1. Mass Spectrometers |
| 12.1.4.2. HPLC |
| 12.1.4.3. MALDI-TOF |
| 12.1.4.4. Array Systems |
| 12.1.4.5. Others |
| 12.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Drug Discovery & Development |
| 12.2.2. Diagnostics |
| 12.2.3. Others |
| 12.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Academic & Research Institutes |
| 12.3.2. Pharmaceutical & Biotechnology Companies |
| 12.3.3. CROs |
| 12.3.4. Others |
| 12.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028 |
| 12.6. Latin America Glycomics/Glycobiology Market Dynamics – Trends |
| 13. Middle East and Africa Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn) |
| 13.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Enzymes |
| 13.1.1.1. Glycosidases |
| 13.1.1.2. Neuraminidases |
| 13.1.1.3. Glycosyltransferases |
| 13.1.1.4. Sialytransferases |
| 13.1.1.5. Others |
| 13.1.2. Kits |
| 13.1.2.1. Glycan Labelling Kits |
| 13.1.2.2. Glycan Purification Kits |
| 13.1.2.3. Glycan Releases Kits |
| 13.1.2.4. Others |
| 13.1.3. Reagents |
| 13.1.3.1. Glycoporteins |
| 13.1.3.2. Monosaccharides |
| 13.1.3.3. Oligosaccharides |
| 13.1.3.4. Others |
| 13.1.4. Instruments |
| 13.1.4.1. Mass Spectrometers |
| 13.1.4.2. HPLC |
| 13.1.4.3. MALDI-TOF |
| 13.1.4.4. Array Systems |
| 13.1.4.5. Others |
| 13.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Drug Discovery & Development |
| 13.2.2. Diagnostics |
| 13.2.3. Others |
| 13.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Academic & Research Institutes |
| 13.3.2. Pharmaceutical & Biotechnology Companies |
| 13.3.3. CROs |
| 13.3.4. Others |
| 13.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028 |
| 13.6. MEA Glycomics/Glycobiology Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis) |
| 14.1.2. Thermo Fisher Scientific, Inc. (US) |
| 14.1.3. Merck KGaA (Germany) |
| 14.1.4. Agilent Technologies (US) |
| 14.1.5. Bruker Corporation (US) |
| 14.1.6. New England Biolabs (US) |
| 14.1.7. Danaher Corporation (US) |
| 14.1.8. Shimadzu Corporation (Japan) |
| 14.1.9. Takara Bio, Inc. (Japan) |
| 14.1.10. Waters Corporation (US) |
| 14.1.11. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan) |
| 14.1.12. RayBiotech (US) |
| 14.1.13. Z Biotech (US) |
| 14.1.14. Chemily Glycoscience (US) |
| 14.1.15. Dextra Laboratories (UK) |
| 14.1.16. Lectenz Bio (US) |
| 14.1.17. Ludger Ltd. (UK) |
| 14.1.18. Asparia Glycomics S.L. (Spain) |
| 14.1.19. Bio-Techne (US) |
| 14.1.20. Other Companies |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Request Sample
Request Methodology
Reviews
There are no reviews yet.